Selective CD47 blockade on CTLA-4 high tumor-infiltrating T reg cells reduces systemic toxicity and enhances antitumor immunity.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: